Viewpoints

Will Drinking More Water Keep Kidney Disease Away? For years, doctors have been recommending drinking more water to their patients. Should they be?
Experts And Viewpoints, August 17, 2021
What You Don't Know About Beta-Blockers and Hemodialysis A new look at the literature turned up a finding that surprised this nephrologist.
Experts And Viewpoints, March 18, 2021
Does Oxygenated Cold Perfusate Improve Transplant Outcomes? If ischemia is a barrier to organ preservation, will the addition of oxygen to cold preservation solutions improve renal transplant outcomes?
Experts And Viewpoints, January 28, 2021
Which Antidiabetic Drug Class is Most Renoprotective? In a clash of the antidiabetic drug titans, which class demonstrates the most renoprotection?
Experts And Viewpoints, December 02, 2020
Myeloma-Induced Acute Kidney Injury: Medicine vs Machine Higher-tech or more aggressive treatment doesn't necessarily mean better, cautions Tejas Desai, MD, in his review of studies on treatment strategies for myeloma-induced acute kidney injury.
Experts And Viewpoints, November 02, 2020
Solutions for Diabetic Ketoacidosis: Finding the Right Balance Can findings in adult patients with sepsis be extrapolated to children with DKA? Studies in pediatric patients give this nephrologist pause.
Experts And Viewpoints, October 02, 2020
Will MRAs Move Higher Up the Hypertension Treatment Pathway? Given new data on selective MRAs (and more to come), will these drugs get more love from nephrologists in the treatment of resistant hypertension?
Experts And Viewpoints, September 04, 2020
Gastric Bypass for Kidney Protection? Obesity takes a toll on the kidney, but weight loss through medications and lifestyle is challenging. A study from Sweden suggests that gastric bypass surgery could help prevent renal decline.
Experts And Viewpoints, August 05, 2020
Could a VA Directive Overhaul Kidney Care? Directive 1053 may have gotten lost in the pandemic news, but it could have widespread implications for the management of CKD by nephrologists and primary care. Tejas Desai, MD, takes a closer look.
Experts And Viewpoints, July 06, 2020
Hypertension in Pregnancy: Which Drug Is Best? Nephrologist Tejas Desai reviews one of the few randomized clinical trials to include pregnant women, comparing three drugs for the safe management of very high blood pressure.
Experts And Viewpoints, June 10, 2020
COVID-19: Don't Forget About Plasmapheresis The strategy to filter out virions from infected plasma has been tested with the Middle East respiratory syndrome coronavirus. Why not consider it for SARS-CoV2, asks nephrologist Tejas Desai.
Experts And Viewpoints, April 28, 2020
Salt Loading in ADHF -- Really? Hypertonic saline in acute decompensated heart failure promotes anxiety in physicians; however, a new study rekindles the idea of promoting natriuresis through increasing renal plasma flow.
Experts And Viewpoints, March 31, 2020
Managing Hypervolemia: Is More Diuretic Better? Dr Tejas Desai compares the seemingly contradictory results of the DOSE and DRAIN trials of loop diuretics in acute decompensated heart failure.
Experts And Viewpoints, February 27, 2020
AIN: Maybe Nephrologists Don't Know It All Are nephrologists too complacent about acute interstitial nephritis? Tejas Desai, MD, reviews recent data suggesting that AIN is on the rise and is a major contributor to acute kidney injury.
Experts And Viewpoints, February 06, 2020
Do PPIs Increase the Risk for Renal Damage or Mortality? Dr Tejas Desai looks into the latest analysis on the potential adverse effects of proton pump inhibitors and asks whether de-escalation measures should be implemented.
Experts And Viewpoints, December 23, 2019
Dialysis Industry Mergers: Profits Rise as Outcomes Worsen An economic analysis of the dialysis industry shows how the usual benefits of mergers are negated in the healthcare industry by imprudent financial incentives and lack of true competitive market forces.
Experts And Viewpoints, December 09, 2019
Promising Biomarkers for Diabetic Nephropathy A big-data analysis identifies various glycolytic pathway enzymes, particularly PKM2, that could serve as potential therapeutic targets for diabetic kidney disease.
Experts And Viewpoints, November 12, 2019
Does Kidney Disease Without AKI Warrant More Attention? An analysis from Canada suggests that acute kidney disease with 'subclinical' acute kidney injury may portend a worse outcome than previously thought.
Experts And Viewpoints, September 24, 2019
Study Underscores Need for Long-term Follow-up After AKI Focusing on eGFR alone may underestimate long-term kidney damage in some patients with AKI, concludes Dr Nisha Bansal in reviewing a new study.
Experts And Viewpoints, August 30, 2019
AKI Prediction Models: Room for Improvement Tejas Desai, MD, discusses the pros and cons of three models used to predict progression or regression of acute kidney injury.
Experts And Viewpoints, August 23, 2019

No Results